Report cover image

Global Cancer Supportive Care Drugs Databank Market Report

Publisher Magna Intelligence
Published Apr 26, 2024
Length 100 Pages
SKU # MAIN18749850

Description

Global Cancer Supportive Care Drugs Databank Market Report


The Cancer Supportive Care Drugs market was valued at $13,359.6 Million in 2020, and is projected to reach $24,003.1 Million by 2029 growing at a CAGR of 6.77% from 2021 to 2029. Bisphosphonates segment is expected to be the highest contributor to this market, with $3,463.6 Million in 2020, and is anticipated to reach $6,456.7 Million by 2029, registering a CAGR of 7.21%. Bisphosphonates and Opioids segments collectively expected to account for about 50.0% share of the Cancer Supportive Care Drugs market in 2020, with the former constituting around 25.9% share. Bisphosphonates and ESAs (Erythropoiesis Stimulating Agents) segments are expected to witness significant growth rates at a CAGR of 7.21% and 7.15% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 38.7% in the overall Cancer Supportive Care Drugs market in 2020, and is anticipated to reach 40.1% by 2029.

Table of Contents

100 Pages
1. Global Cancer Supportive Care Drugs Market, By Therapeutic Class
1.1. Overview
1.2. Anti-emetics
1.2.1 Anti-emetics Market, By Region
1.2.1.1 North America Anti-emetics Market, By Country
1.2.1.2 Europe Anti-emetics Market, By Country
1.2.1.3 Asia-Pacific Anti-emetics Market, By Country
1.2.1.4 Rest of World Anti-emetics Market, By Country
1.3. G-CSFs (Granulocyte-colony Stimulating Factors)
1.3.1 G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Region
1.3.1.1 North America G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Country
1.3.1.2 Europe G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Country
1.3.1.3 Asia-Pacific G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Country
1.3.1.4 Rest of World G-CSFs (Granulocyte-colony Stimulating Factors) Market, By Country
1.4. Bisphosphonates
1.4.1 Bisphosphonates Market, By Region
1.4.1.1 North America Bisphosphonates Market, By Country
1.4.1.2 Europe Bisphosphonates Market, By Country
1.4.1.3 Asia-Pacific Bisphosphonates Market, By Country
1.4.1.4 Rest of World Bisphosphonates Market, By Country
1.5. ESAs (Erythropoiesis Stimulating Agents)
1.5.1 ESAs (Erythropoiesis Stimulating Agents) Market, By Region
1.5.1.1 North America ESAs (Erythropoiesis Stimulating Agents) Market, By Country
1.5.1.2 Europe ESAs (Erythropoiesis Stimulating Agents) Market, By Country
1.5.1.3 Asia-Pacific ESAs (Erythropoiesis Stimulating Agents) Market, By Country
1.5.1.4 Rest of World ESAs (Erythropoiesis Stimulating Agents) Market, By Country
1.6. Opioids
1.6.1 Opioids Market, By Region
1.6.1.1 North America Opioids Market, By Country
1.6.1.2 Europe Opioids Market, By Country
1.6.1.3 Asia-Pacific Opioids Market, By Country
1.6.1.4 Rest of World Opioids Market, By Country
1.7. NSAIDs and others
1.7.1 NSAIDs and others Market, By Region
1.7.1.1 North America NSAIDs and others Market, By Country
1.7.1.2 Europe NSAIDs and others Market, By Country
1.7.1.3 Asia-Pacific NSAIDs and others Market, By Country
1.7.1.4 Rest of World NSAIDs and others Market, By Country
2. Global Cancer Supportive Care Drugs Market, By Region
2.1. Overview
2.2. North America
2.2.1 North America Cancer Supportive Care Drugs Market, By Therapeutic Class
2.2.2 North America Cancer Supportive Care Drugs Market, By Country
2.2.2.1 U.S.
2.2.2.1.1 U.S. Cancer Supportive Care Drugs Market, By Therapeutic Class
2.2.2.2 Canada
2.2.2.2.1 Canada Cancer Supportive Care Drugs Market, By Therapeutic Class
2.2.2.3 Mexico
2.2.2.3.1 Mexico Cancer Supportive Care Drugs Market, By Therapeutic Class
2.3. Europe
2.3.1 Europe Cancer Supportive Care Drugs Market, By Therapeutic Class
2.3.2 Europe Cancer Supportive Care Drugs Market, By Country
2.3.2.1 Germany
2.3.2.1.1 Germany Cancer Supportive Care Drugs Market, By Therapeutic Class
2.3.2.2 France
2.3.2.2.1 France Cancer Supportive Care Drugs Market, By Therapeutic Class
2.3.2.3 U.K.
2.3.2.3.1 U.K. Cancer Supportive Care Drugs Market, By Therapeutic Class
2.3.2.4 Italy
2.3.2.4.1 Italy Cancer Supportive Care Drugs Market, By Therapeutic Class
2.3.2.5 Spain
2.3.2.5.1 Spain Cancer Supportive Care Drugs Market, By Therapeutic Class
2.3.2.6 Rest of Europe
2.3.2.6.1 Rest of Europe Cancer Supportive Care Drugs Market, By Therapeutic Class
2.4. Asia-Pacific
2.4.1 Asia-Pacific Cancer Supportive Care Drugs Market, By Therapeutic Class
2.4.2 Asia-Pacific Cancer Supportive Care Drugs Market, By Country
2.4.2.1 China
2.4.2.1.1 China Cancer Supportive Care Drugs Market, By Therapeutic Class
2.4.2.2 India
2.4.2.2.1 India Cancer Supportive Care Drugs Market, By Therapeutic Class
2.4.2.3 Japan
2.4.2.3.1 Japan Cancer Supportive Care Drugs Market, By Therapeutic Class
2.4.2.4 Australia
2.4.2.4.1 Australia Cancer Supportive Care Drugs Market, By Therapeutic Class
2.4.2.5 South Korea
2.4.2.5.1 South Korea Cancer Supportive Care Drugs Market, By Therapeutic Class
2.4.2.6 Rest of Asia
2.4.2.6.1 Rest of Asia Cancer Supportive Care Drugs Market, By Therapeutic Class
2.5. Rest of World
2.5.1 Rest of World Cancer Supportive Care Drugs Market, By Therapeutic Class
2.5.2 Rest of World Cancer Supportive Care Drugs Market, By Country
2.5.2.1 Brazil
2.5.2.1.1 Brazil Cancer Supportive Care Drugs Market, By Therapeutic Class
2.5.2.2 South Africa
2.5.2.2.1 South Africa Cancer Supportive Care Drugs Market, By Therapeutic Class
2.5.2.3 GCC
2.5.2.3.1 GCC Cancer Supportive Care Drugs Market, By Therapeutic Class
2.5.2.4 RoW Countries
2.5.2.4.1 RoW Countries Cancer Supportive Care Drugs Market, By Therapeutic Class
RoW Countries Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD LIST OF TABLES
TABLE 1. Global Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 2. Anti-emetics Market Value, By Region, 2020-2029, Million USD
TABLE 3. North America Anti-emetics Market Value, By Country, 2020-2029, Million USD
TABLE 4. Europe Anti-emetics Market Value, By Country, 2020-2029, Million USD
TABLE 5. Asia-Pacific Anti-emetics Market Value, By Country, 2020-2029, Million USD
TABLE 6. Rest of World Anti-emetics Market Value, By Country, 2020-2029, Million USD
TABLE 7. G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Region, 2020-2029, Million USD
TABLE 8. North America G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Country, 2020-2029, Million USD
TABLE 9. Europe G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Country, 2020-2029, Million USD
TABLE 10. Asia-Pacific G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Country, 2020-2029, Million USD
TABLE 11. Rest of World G-CSFs (Granulocyte-colony Stimulating Factors) Market Value, By Country, 2020-2029, Million USD
TABLE 12. Bisphosphonates Market Value, By Region, 2020-2029, Million USD
TABLE 13. North America Bisphosphonates Market Value, By Country, 2020-2029, Million USD
TABLE 14. Europe Bisphosphonates Market Value, By Country, 2020-2029, Million USD
TABLE 15. Asia-Pacific Bisphosphonates Market Value, By Country, 2020-2029, Million USD
TABLE 16. Rest of World Bisphosphonates Market Value, By Country, 2020-2029, Million USD
TABLE 17. ESAs (Erythropoiesis Stimulating Agents) Market Value, By Region, 2020-2029, Million USD
TABLE 18. North America ESAs (Erythropoiesis Stimulating Agents) Market Value, By Country, 2020-2029, Million USD
TABLE 19. Europe ESAs (Erythropoiesis Stimulating Agents) Market Value, By Country, 2020-2029, Million USD
TABLE 20. Asia-Pacific ESAs (Erythropoiesis Stimulating Agents) Market Value, By Country, 2020-2029, Million USD
TABLE 21. Rest of World ESAs (Erythropoiesis Stimulating Agents) Market Value, By Country, 2020-2029, Million USD
TABLE 22. Opioids Market Value, By Region, 2020-2029, Million USD
TABLE 23. North America Opioids Market Value, By Country, 2020-2029, Million USD
TABLE 24. Europe Opioids Market Value, By Country, 2020-2029, Million USD
TABLE 25. Asia-Pacific Opioids Market Value, By Country, 2020-2029, Million USD
TABLE 26. Rest of World Opioids Market Value, By Country, 2020-2029, Million USD
TABLE 27. NSAIDs and others Market Value, By Region, 2020-2029, Million USD
TABLE 28. North America NSAIDs and others Market Value, By Country, 2020-2029, Million USD
TABLE 29. Europe NSAIDs and others Market Value, By Country, 2020-2029, Million USD
TABLE 30. Asia-Pacific NSAIDs and others Market Value, By Country, 2020-2029, Million USD
TABLE 31. Rest of World NSAIDs and others Market Value, By Country, 2020-2029, Million USD
TABLE 32. Global Cancer Supportive Care Drugs Market Value, By Region, 2020-2029, Million USD
TABLE 33. North America Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 34. North America Cancer Supportive Care Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 35. U.S. Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 36. Canada Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 37. Mexico Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 38. Europe Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 39. Europe Cancer Supportive Care Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 40. Germany Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 41. France Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 42. U.K. Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 43. Italy Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 44. Spain Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 45. Rest of Europe Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 46. Asia-Pacific Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 47. Asia-Pacific Cancer Supportive Care Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 48. China Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 49. India Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 50. Japan Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 51. Australia Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 52. South Korea Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 53. Rest of Asia Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 54. Rest of World Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 55. Rest of World Cancer Supportive Care Drugs Market Value, By Country, 2020-2029, Million USD
TABLE 56. Brazil Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 57. South Africa Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 58. GCC Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
TABLE 59. RoW Countries Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD
RoW Countries Cancer Supportive Care Drugs Market Value, By Therapeutic Class, 2020-2029, Million USD

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us